Refractory Epilepsy: One Size Does Not Fit All

A unifying definition of refractory epilepsy has been hotly debated but, to date, has not been agreed upon. Evidence from clinical trials indicates that some patients actually are not refractory, as many will partially respond to add-on treatment or will worsen when antiepileptic drugs (AEDs) are removed. There are several important issues relating to the assessment of AED response that routinely have not been addressed in the determination of treatment responsiveness, such as incorporating baseline seizure severity, including partial response rather than solely an all-or-none response, and the consideration of variability in response over time.

[1]  Dieter Schmidt,et al.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. , 2006, Brain : a journal of neurology.

[2]  M. Brodie,et al.  Diagnosing refractory epilepsy: response to sequential treatment schedules , 2006, European journal of neurology.

[3]  Yun-Sil Lee,et al.  Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. , 2006, Clinical pharmacology and therapeutics.

[4]  D. Spencer,et al.  Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination , 1993, Annals of neurology.

[5]  M. Baulac.  Historical data in the design and interpretation of trials with newly diagnosed patients , 2006, Epilepsy Research.

[6]  D. Goldstein,et al.  Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. , 2003, The New England journal of medicine.

[7]  S. Benbadis.  Is the underlying cause of epilepsy a major prognostic factor for recurrence? , 1999, Neurology.

[8]  J. Farrar,et al.  Response to first drug trial predicts outcome in childhood temporal lobe epilepsy , 2001, Neurology.

[9]  A. Berg,et al.  Defining Intractability: Comparisons among Published Definitions , 2006, Epilepsia.

[10]  M. Sperling,et al.  Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. , 2001, The Cochrane database of systematic reviews.

[11]  W. Hauser,et al.  Remission of Seizures and Relapse in Patients with Epilepsy , 1979, Epilepsia.

[12]  K. Heo,et al.  Antiepileptic Drug Withdrawal after Successful Surgery for Intractable Temporal Lobe Epilepsy , 2005, Epilepsia.

[13]  G. Holmes,et al.  Predicting medical intractability of epilepsy in children , 2001, Neurology.

[14]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[15]  N. Ebrahimi,et al.  Defining early seizure outcomes in pediatric epilepsy: the good, the bad and the in-between , 2001, Epilepsy Research.

[16]  L. Bongiovanni,et al.  Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long‐Term Course of Epilepsy , 1992, Epilepsia.

[17]  P. Ryvlin,et al.  Defining success in clinical trials – profiling pregabalin, the newest AED , 2005, European journal of neurology.

[18]  S Shinnar,et al.  How long does it take for partial epilepsy to become intractable? , 2003, Neurology.

[19]  M. Doherty.  How long does it take for partial epilepsy to become intractable? , 2003, Neurology.

[20]  E H Reynolds,et al.  The prognosis for seizure control in newly diagnosed epilepsy. , 1984, The New England journal of medicine.

[21]  C. V. van Donselaar,et al.  Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. , 2004, Brain : a journal of neurology.

[22]  C. Baumgartner,et al.  Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy , 2004, Neurology.

[23]  S Shinnar,et al.  Early development of intractable epilepsy in children , 2001, Neurology.

[24]  J. Cramer,et al.  Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures , 1996, Neurology.